American Academy of Neurology 56th Annual Meeting
San Francisco, April 24th - May 1st, 2004

Dystonia

• BTX for Dystonias (AAN 2004)
• Dystonia: Altered Biochemistry of TorsinA, Genetics (AAN 2004)

Movement Disorders and related conditions

• Psychogenic Movement Disorders (AAN 2004)

Parkinson's disease

• Rasagiline Versus Entacapone in PD (AAN 2004)
• PD: New Treatment Strategies in Animal Models (AAN 2004)
• PD Dopamine Agonist Treatment (AAN 2004)
• PD: Medication Errors, Most Troubling Symptoms (AAN 2004)
• Acetylcholinesterase Inhibitors for PD Dementia (AAN 2004)
• Hallucinations in Advanced PD (AAN 2004)
• Genetic Risk Factors in PD, part 1 (AAN 2004)
• Genetic Risk Factors for PD, part 2 (AAN 2004)
• Long-term Results of GDNF Pilot Trial; Gene Therapy in Animal Model (AAN 2004)
• Parkin Interacts with Ataxin2 and Synaptic Vesicle Proteins (AAN 2004)

Restless legs syndrome

• RLS: Pilot Trials of New Therapies (AAN 2004)
• Dopamine Agonists for RLS (AAN 2004)
• RLS Prevalence, Diagnosis, and Severity (AAN 2004)

Rett syndrome

• Pediatric Movement Disorders (AAN 2004)

Tardive dyskinesia/Dystonia

• Tardive Dyskinesia Treatment and Risk Factors (AAN 2004)

Tics/Tourette's syndrome

• Pediatric Movement Disorders (AAN 2004)

Tremor

• Essential Tremor Update (AAN 2004)

Meeting Reports Menu